MicroGenDX Selected for 2022 Israeli Space Mission Study Researchers Seek Solutions to Astronauts' Urinary Tract Infections During Space Travel News provided by Share this article in the study. "We're honored and excited to be part of this study to evaluate the impact of space travel on the urinary microbiome," says Rick Martin, CEO of MicroGenDX. "MicroGenDX is uniquely qualified to provide this data for analysis that could be the basis for future solutions to astronaut medical care. This work will help shape the future of long-term space missions — including the multi-year Mars mission." Researchers Seek Solutions to Astronauts' Urinary Tract Infections During Space Travel